Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages 3240-3246

  Berger, P K ^a   Pollock, N K ^b   Laing, E M ^a   Warden, S J ^c   Hill Gallant, K M ^c,d   Hausman, D B ^a   Tripp, R A ^f   McCabe, L D ^d   McCabe, G P ^e   Weaver, C M ^d   Peacock, M ^c   Lewis, R D ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c INDIANA UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

^f UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VIRUS ANTIBODY; CCL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADENOVIRUS 36 INFECTION; ADENOVIRUS INFECTION; ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SOFT TISSUE; ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; INFLAMMATION; PREVALENCE; RISK;

ADENOVIRIDAE; ADENOVIRUS INFECTIONS, HUMAN; ADIPOSITY; ADOLESCENT; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHILD; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; ODDS RATIO; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907222574     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1780     Document Type: Article

References (34)

1. Atkinson RL, Lee I, Shin HJ, He J. Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes. 2010; 5(2): 157-160.
2. Almgren M, Atkinson R, He J, et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One. 2012; 7(7): e41652.
3. Aldhoon-Hainerová I, Zamrazilová H, Atkinson RL, et al. Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36. Int J Obes (Lond). 2014; 38(2): 285-291.
4. Yamada T, Hara K, Kadowaki T. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a metaanalysis of observational studies. PLoS One. 2012; 7(7): e42031.
5. Shang Q, Wang H, Song Y, et al. Serological data analyses show that adenovirus 36 infection is associated with obesity: a meta-Analysis involving 5739 subjects. Obesity (Silver Spring). 2014; 22(3): 895-900.
6. Atkinson RL. Adenovirus-36 and obesity. Microbe Magazine, 2012. http://www.microbemagazine.org/index.php?option-com-content& view-Article&id-5068: virus-induced-obesity-in-humans&Itemid-1252. Accessed August 12, 2013.
7. Pasarica M, Mashtalir N, McAllister EJ, et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells. 2008; 26(4): 969-978.
8. Rathod M, Vangipuram SD, Krishnan B, Heydari AR, Holland TC, Dhurandhar NV. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond). 2007; 31(1): 78-86.
9. Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis. 2012; 205(6): 914-922.
10. Gabbert C, Donohue M, Arnold J, Schwimmer JB. Adenovirus 36 and obesity in children and adolescents. Pediatrics. 2010; 126(4): 721-726.
11. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association betweenhumanadenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond). 2010; 34(1): 89-93.
12. Goossens VJ, de Jager SA, Grauls GE, et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring). 2011; 19(1): 220-221.
13. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004; 15(11): 2792-2800.
14. Na HN, Kim H,Nam JH. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Int J Obes (Lond). 2012; 36(2): 195-200.
15. Breslin WL, Johnston CA, Strohacker K, et al. Obese Mexican American children have elevated MCP-1, TNF-, monocyte concentration, and dyslipidemia. Pediatrics. 2012; 129(5): e1180-e1186.
16. Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ. Infectioninduced inflammatory response of adipocytes in vitro. Int J Obes (Lond). 2008; 32(6): 892-901.
17. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12): 1796-1808.
18. Desruisseaux MS, Nagajyothi, Trujillo ME, Tanowitz HB, Scherer PE. Adipocyte, adipose tissue, and infectious disease. Infect Immun. 2007; 75(3): 1066-1078.
19. Lewis RD, Laing EM, Hill Gallant KM, et al. A randomized trial of vitamin D3 supplementation in children: dose-response effects on vitamin D metabolites and calcium absorption. J Clin Endocrinol Metab. 2013; 98(12): 4816-4825.
20. Tanner J. Growth and Adolescence. 2nd ed. Oxford, UK: Blackwell Scientific; 1962.
21. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics; 1988.
22. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; (314): 1-27.
23. Warden SJ, Hill KM, Ferira AJ, et al. Racial differences in cortical bone and their relationship to biochemical variables in black and white children in the early stages of puberty. Osteoporos Int. 2013; 24(6): 1869-1879.
24. Laing EM, Tripp RA, Pollock NK, et al. Adenovirus 36, adiposity, and bone strength in late-Adolescent females. J Bone Miner Res. 2013; 28(3): 489-496.
25. Broderick MP, Hansen CJ, Irvine M, et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond). 2010; 34(2): 302-308.
26. Parra-Rojas I, Del Moral-Hernández O, Salgado-Bernabé AB, Guzmán-Guzmán IP, Salgado-Goytia L, Muñoz-Valle JF. Adenovirus-36 seropositivity and its relation with obesity and metabolic profile in children. Int J Endocrinol. 2013; 2013: 463194.
27. Mancuso P. Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther. 2013; 26(4): 412-419.
28. Wang S1, Liu Z, Wang L, Zhang X. NF-B signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009; 6(5): 327-334.
29. Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care. 2010; 13(4): 371-376.
30. Apovian CM, Bigornia S, Mott M, et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol. 2008; 28(9): 1654-1659.
31. Rega G, Kaun C, Demyanets S, et al. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatinMin human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol. 2007; 27(7): 1587-1595.
32. Duncan BB, Schmidt MI, Pankow JS, et al. Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003; 52(7): 1799-1805.
33. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19(4): 972-978.
34. Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2007; 49(2): 304-310.